In silico trial of baroreflex activation therapy for the treatment of obesity-induced hypertension.
Clinical trials evaluating the efficacy of chronic electrical stimulation of the carotid baroreflex for the treatment of hypertension (HTN) are ongoing. However, the mechanisms by which this device lowers blood pressure (BP) are unclear, and it is uncertain which patients are most likely to receive...
Main Authors: | John S Clemmer, W Andrew Pruett, Robert L Hester |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2021-01-01
|
Series: | PLoS ONE |
Online Access: | https://doi.org/10.1371/journal.pone.0259917 |
Similar Items
-
Baroreflex Activation Therapy for Resistant Hypertension and Heart Failure
by: Anna Meta Dyrvig Kristensen, et al.
Published: (2020-02-01) -
Effect of baroreflex activation therapy on dipping pattern in patients with resistant hypertension
by: Manuel Wallbach, et al.
Published: (2023-01-01) -
Eligibility for Baroreflex Activation Therapy and medication adherence in patients with apparently resistant hypertension
by: Ann‐Kathrin Schäfer, et al.
Published: (2021-07-01) -
Efficacy and safety of baroreflex activation therapy for treatment of resistant hypertension: a systematic review and meta-analysis
by: Wang Chunbin, et al.
Published: (2018-08-01) -
Sympathetic activation and baroreflex function during intradialytic hypertensive episodes.
by: Dvora Rubinger, et al.
Published: (2012-01-01)